Stay updated with breaking news from Tuberculosis Regimens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has received a US$ 6.6 m grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis (“TB”). The grant is the second award from the foundation to Evotec supporting TB drug ...
Evotec SE (Frankfurt Stock...
EQS-News: Evotec SE / Key word: Miscellaneous Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis 24.03.2023 / 07:30 CET/CEST The issuer is solely responsible for... | March 24, 2023
GRANT FROM THE BILL & MELINDA GATES FOUNDATION SUPPORTS EVOTEC'S EFFORTS TO DISCOVER AND DEVELOP DRUG CANDIDATES FOR A UNIVERSAL, SHORTER, SAFER AND SIMPLER TUBERCULOSIS DRUG REGIMEN AS ONE OF ITS PROGRAMMES